Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Plerixafor, sold under the brand name Mozobil, is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream. The stem cells are then extracted from the blood and transplanted back to the patient. The drug was developed by AnorMED, which was subsequently bought by Genzyme.
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Plerixafor.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Plerixafor shows recurring relationship patterns in the source. For example, Plerixafor → Canada, Committee, December, Drug Administration, European Union, FDA, Food, Health Canada, Human Use, In, It, May, Medicinal Products, The, United States Another extracted example is Plerixafor → Additionally, CD20, CXCR4, CXCR4/SDF1, CXCR7, In, SDF-1, The, The CXCR4. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
cells stem drug cxcr4 patients studies hematopoietic use blood cell approved found cancer zinc effects interactions hours model name mozobil
TTTA extracted 96 structured relationships around Plerixafor. Examples in this analysis include Plerixafor → 3D model (JSmol) → Interactive image and Plerixafor → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Plerixafor | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Plerixafor | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Plerixafor | ATC code | L03AX16 (WHO) | 1.00 | infobox |
| Plerixafor | CAS Number | 110078-46-1 Y | 1.00 | infobox |
| Plerixafor | CAS Number | as salt: 155148-31-5 Y | 1.00 | infobox |
| Plerixafor | ChEBI | CHEBI:125354 | 1.00 | infobox |
| Plerixafor | ChEMBL | ChEMBL18442 Y | 1.00 | infobox |
| Plerixafor | ChemSpider | 58531 Y | 1.00 | infobox |
| Plerixafor | CompTox Dashboard (EPA) | DTXSID70869520 | 1.00 | infobox |
| Plerixafor | DrugBank | DB06809 Y | 1.00 | infobox |
| Plerixafor | Elimination half-life | 3–5 hours | 1.00 | infobox |
| Plerixafor | Excretion | Kidney | 1.00 | infobox |
| Plerixafor | Formula | C28H54N8 | 1.00 | infobox |
| Plerixafor | IUPHAR/BPS | 844 | 1.00 | infobox |
| Plerixafor | KEGG | D08971 Y | 1.00 | infobox |
| Plerixafor | Legal status | CA: ℞-only | 1.00 | infobox |
| Plerixafor | Legal status | US: ℞-only | 1.00 | infobox |
| Plerixafor | Legal status | EU: Rx-only | 1.00 | infobox |
| Plerixafor | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Plerixafor | License data | US DailyMed: Plerixafor | 1.00 | infobox |
| Plerixafor | MedlinePlus | a609018 | 1.00 | infobox |
| Plerixafor | Metabolism | None | 1.00 | infobox |
| Plerixafor | Molar mass | 502.796 g·mol−1 | 1.00 | infobox |
| Plerixafor | Other names | JM 3100, AMD3100 | 1.00 | infobox |
| Plerixafor | Pregnancy category | AU: D | 1.00 | infobox |
| Plerixafor | Protein binding | Up to 58% | 1.00 | infobox |
| Plerixafor | PubChem CID | 65015 | 1.00 | infobox |
| Plerixafor | Routes of administration | Subcutaneous | 1.00 | infobox |
| Plerixafor | Trade names | Mozobil | 1.00 | infobox |
| Plerixafor | UNII | S915P5499N | 1.00 | infobox |
The concept neighborhoods around Plerixafor bring nearby vocabulary together. In this analysis, examples include Cells, Stem and Cxcr4. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Plerixafor, one of the stronger structural bridges in this analysis connects Plerixafor with Pharmacology. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Plerixafor to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Plerixafor · EN edition · Analysis: TopicsToTalkAbout